In the current study, we investigated the short-term effects of a GHRH analog, tesamorelin, which has been shown to reduce visceral adipose tissue (VAT) in patients with HIV-associated abdominal adiposity (20,21)
Available as: Last cited 6 Sept 2023 Urva S, OFarrell L, Du Y, Loh MT, Hemmingway A, Qu H, Alsina-Fernandez J, Haupt A, Milicevic Z, Coskun T (2023) The novel GIP, GLP-1 and glucagon receptor agonist retatrutide delays gastric emptying
While levothyroxine itself is not a direct antagonist to sermorelin, thyroid levels need to be stable
Moreover, while many of the reviewed studies reported promising feasibility and adherence to VR-based interventions, these results were mostly obtained in highly structured clinical or research environments